Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-8-4
pubmed:abstractText
The aim of this study was to compare omeprazole (20 mg once daily) with placebo in the long-term prevention of gastroduodenal lesions induced by indomethacin, diclofenac and ketoprofen.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1125-8055
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
43-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9615264-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:9615264-Anti-Ulcer Agents, pubmed-meshheading:9615264-Diclofenac, pubmed-meshheading:9615264-Double-Blind Method, pubmed-meshheading:9615264-Endoscopy, Digestive System, pubmed-meshheading:9615264-Female, pubmed-meshheading:9615264-Follow-Up Studies, pubmed-meshheading:9615264-Gastric Mucosa, pubmed-meshheading:9615264-Humans, pubmed-meshheading:9615264-Indomethacin, pubmed-meshheading:9615264-Intestinal Mucosa, pubmed-meshheading:9615264-Ketoprofen, pubmed-meshheading:9615264-Male, pubmed-meshheading:9615264-Middle Aged, pubmed-meshheading:9615264-Omeprazole, pubmed-meshheading:9615264-Peptic Ulcer, pubmed-meshheading:9615264-Rheumatic Diseases, pubmed-meshheading:9615264-Safety, pubmed-meshheading:9615264-Treatment Outcome
pubmed:year
1998
pubmed:articleTitle
Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
pubmed:affiliation
Gastro-intestinal Unit, L. Sacco University Hospital, Milano, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial